Interestingly, recent evidences indicate that GLP1R agonists can significantly reduce adverse cardiovascular events, renal dysfunction, and the incidence of stroke in the patients with diabetes 9,10,11,12
Use caution in a patient with a history of angioedema or anaphylaxis with another GLP-1 receptor agonist because it is unknown whether such patients will be predisposed to anaphylaxis with RYBELSUS or OZEMPIC tablets
These collective findings suggest that the functional and compositional characteristics of the healthy gut microbiota in pediatric individuals differ from those of healthy adults with similar characteristics
Previous reports that the products could have detrimental mental health side effects led to increased scrutiny of the drugs, raising fears that they might pose a risk to mental health
A., Rstam, L., Larsson, C
Canada is the only country where Novo Nordisk allowed the patent for its semaglutide drugs to expire, paving the way for regulatory exclusivity to end on Jan